Evolution of the Average Target: Bayer AG

Evolution of the Target Price: Bayer AG

Changes in Analyst Recommendations: Bayer AG

5c.YaHdFeCrbDcdTD0qem0Of4VTOTeDMVGGYVP0AdIXCpU.N-e5SrjfBn8vfndzCgZnS_AkdE6yQhv_VDHDQ4NPYcZR2658mfopZXMgXg~4c166dff520de18722372a19c3d0baa5
06-19 Sadif Investment Analytics Downgrades Bayer to Sell, Lifts PT MT
06-18 AlphaValue/Baader Europe Downgrades Bayer to Add, Lifts PT MT
06-18 BAYER AG : Receives a Buy rating from UBS ZD
06-17 BAYER AG : Jefferies reiterates its Neutral rating ZD
06-17 Bayer Hits Monthly High Despite Legal Ambiguity in the U.S. DP
06-17 Bayer Hits Monthly High Despite Legal Ambiguities in the U.S. DP
06-17 UBS Projects $28 Price Target for Bayer in 'Worst-Case' Scenario DP
06-17 BAYER AG : UBS gives a Buy rating ZD
06-15 Berenberg Ups Bayer's Price Target, Estimates; Hold Rating Amid Settlement Uncertainty MT
06-12 Berenberg remains cautious on Bayer amid ongoing US litigation Zonebourse
06-12 Berenberg remains cautious on Bayer amid U.S. litigation Zonebourse
06-12 BAYER AG : Gets a Neutral rating from Berenberg ZD
06-12 Berenberg Raises Bayer Price Target to €40.50, Maintains 'Hold' Rating DP
06-09 BAYER AG : UBS keeps its Buy rating ZD
06-05 BAYER AG : UBS maintains a Buy rating ZD
06-05 UBS maintains 'Buy' rating on Bayer - Target 52 euros DP
06-03 AlphaValue/Baader Europe Upgrades Bayer to Buy, Trims PT MT
06-03 Mwb Says Bayer Valuation Discounts US Legal Overhang; Buy Rating Kept MT
06-03 Bayer Rating Maintained at Buy as BofA Notes Transfer of Roundup Class Action Lawsuit MT
05-29 Bayer stock in the red as market scrutinizes legal disputes Zonebourse
05-29 Bayer in the Red as Legal Liabilities Remain Under Scrutiny Zonebourse
05-29 BAYER AG : Jefferies gives a Neutral rating ZD
05-29 Jefferies raises Bayer target to 40 euros, 'Hold' - New analyst DP
05-28 BAYER AG : UBS remains its Buy rating ZD
05-19 BAYER AG : DZ Bank takes a positive view ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+10.94%
+10.72%
+17.12%
+12.21%
+26.26%
+5.72%
+7.33%
+4.49%
+27.32%
Average +13.57%
Weighted average by Cap. +12.76%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
37.84EUR
Average target price
49.50EUR
Spread / Average Target
+30.81%
High Price Target
60.00EUR
Spread / Highest target
+58.56%
Low Price Target
30.00EUR
Spread / Lowest Target
-20.72%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Sadif Investment Analytics
AlphaValue/Baader Europe
UBS Matthew Weston
JEFFERIES Michael Leuchten
BERENBERG Sebastian Bray
DZ BANK Peter Spengler
BARCLAYS Charles Pitman-King
JPMORGAN Richard Vosser
alphavalue Abhishek Raval
Rothschild & Co Redburn
GOLDMAN SACHS James Quigley
ODDO BHF
Morningstar
MWB Research
BANK OF AMERICA (BOFA) Sachin Jain
BERNSTEIN RESEARCH Florent Cespedes
Baptista Research
HSBC
DEUTSCHE BANK RESEARCH Falko Friedrichs
STIFEL Andreas Heine
Stifel Nicolaus
MORGAN STANLEY Thibault Boutherin
CREDIT SUISSE Dominic Lunn
DEUTSCHE BANK Falko Friedrichs
KEPLER CHEUVREUX Christian Faitz
NORDLB Thorsten Strauß
WARBURG RESEARCH Ulrich Huwald
BRYAN GARNIER Jean-Jaques Le Fur
INDEPENDENT RESEARCH Tobias Gottschalt
BAADER BANK Markus Mayer
LIBERUM CAPITAL Graham Doyle
SOCIETE GENERALE (SOCGEN) Florent Cespedes
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
37.84EUR
Average target price
49.50EUR
Spread / Average Target
+30.81%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!